Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Who it is for: Individuals experiencing persistent fatigue, poor concentration, or low mood despite adequate sleep
Cohen AA, van Doremalen N, Greaney AJ, Andersen H, Sharma A, Starr TN, et al
Spherical Insights has segmented the Global IV Glutathione Treatment Market based on the following segments: Global IV Glutathione Treatment Market, By Treatment Type Skin Whitening & Aesthetic Treatments Antioxidant Therapy Liver Detoxification & Support Anti-Aging Therapy Neurological & Immune Support Others Global IV Glutathione Treatment Market, By Application Aesthetic & Skin Brightening Wellness & Anti-Aging Therapeutic & Medical Treatments Global IV Glutathione Treatment Market, By End User Hospitals Specialty Clinics Dermatology Clinics Wellness & Medical Spa Centers Others Global IV Glutathione Treatment Market, By Regional Analysis North America US Canada Mexico Europe Germany UK France Italy Spain Russia Rest of Europe Asia Pacific China Japan India South Korea Australia Rest of Asia Pacific South America Brazil Argentina Rest of South America Middle East & Africa UAE Saudi Arabia Qatar South Africa Rest of the Middle East & Africa Frequently Asked Questions (FAQ) How is the growing wellness tourism industry influencing the IV glutathione treatment market?The expansion of wellness tourism is increasing demand for premium IV infusion therapies, particularly in destinations offering integrated aesthetic, preventive healthcare, and anti-aging services
Common Research Areas Associated With GHK-CU Collagen synthesis and fibroblast support Skin remodeling and wound-healing pathways Extracellular matrix regulation Anti-inflammatory and antioxidant signaling Hair and skin-related regenerative interest Published research has linked GHK and GHK-CU to tissue remodeling, collagen support, and gene-regulatory activity in experimental models
For a breakdown into the Wolverine Stack, read our
Applications in Research As a molecular probe for studying VPAC receptor binding and activation Investigation of neuroendocrine and neuroimmune signalling pathways In vitro studies examining peptide-mediated smooth muscle and neuronal signalling Use as a reference neuropeptide in receptor pharmacology research Handling, Reconstitution & Stability Reconstitute in sterile water or appropriate buffered aqueous solution depending on assay requirements Avoid vigorous agitation during dissolution Aliquot reconstituted solutions to minimise repeated freezethaw cycles Store reconstituted peptide at 20 C or lower for long-term stability Protect from prolonged exposure to light and elevated temperatures Specifications Summary Purity: 99 % (HPLC) Appearance: White to off-white lyophilised powder Peptide Length: 28 amino acids Molecular Weight: 3325.83 g/mol CAS: 40077-57-4 Storage: 20 C, desiccated, protected from light Precautions & Notes Experimental behaviour of VIP is influenced by receptor expression, concentration, and exposure duration Neuropeptide signalling responses may vary across experimental models Buffer composition and pH may affect peptide stability and assay performance Intended strictly for laboratory research use
